2013
DOI: 10.1136/jnnp-2013-304993
|View full text |Cite
|
Sign up to set email alerts
|

Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia

Abstract: Ophthalmoplegia can be absent or incomplete in BBE, and the absence of this clinical feature should not exclude BBE from the clinicians' differential. Such cases of incomplete BBE could be defined as 'ataxic hypersomnolence without ophthalmoplegia'.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
11
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 13 publications
(17 reference statements)
0
11
0
Order By: Relevance
“…Another explanation is the diverse fine specificities of anti-GQ1b antibodies, which have already been investigated within PNS phenotypes of anti-GQ1b antibody syndrome: anti-GQ1b antibodies from MFS patients rarely cross-react with GD1b ganglioside, whereas those from patients with acute sensory ataxic neuropathy without ophthalmoplegia frequently do 5. Disappointingly, data regarding the cross-reactivity of anti-GQ1b antibodies are not available in the current description3 and it is impossible to evaluate this hypothesis in the CNS phenotypes of anti-GQ1b antibody syndrome. If this is true also in the CNS phenotypes, we should open the door for further assessment of anti-ganglioside antibodies in the CNS disorders.…”
mentioning
confidence: 89%
See 2 more Smart Citations
“…Another explanation is the diverse fine specificities of anti-GQ1b antibodies, which have already been investigated within PNS phenotypes of anti-GQ1b antibody syndrome: anti-GQ1b antibodies from MFS patients rarely cross-react with GD1b ganglioside, whereas those from patients with acute sensory ataxic neuropathy without ophthalmoplegia frequently do 5. Disappointingly, data regarding the cross-reactivity of anti-GQ1b antibodies are not available in the current description3 and it is impossible to evaluate this hypothesis in the CNS phenotypes of anti-GQ1b antibody syndrome. If this is true also in the CNS phenotypes, we should open the door for further assessment of anti-ganglioside antibodies in the CNS disorders.…”
mentioning
confidence: 89%
“…Wakerley et al 3 describe two cases of atypical CNS phenotype of anti-GQ1b antibody syndrome, in which the neurological picture and clinical course resemble that of BBE, except for absent or incomplete ophthalmoplegia. Ophthalmoplegia is often the predominant feature in BBE and, conversely, lack of ophthalmoplegia in cases of brainstem encephalitis has been recognised as the important cue for unlikeliness of anti-GQ1b antibody syndrome.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The report by Wakerley et al 4 describes two patients presenting acute ataxia and hypersomnolence without ophthalmoplegia, and anti-ganglioside assay showed high titer of serum IgG anti-GQ1b antibodies. One patient received immunoglobulin therapy and had returned to normal 4 weeks later, whereas the other had spontaneous recovery within 4 weeks.…”
mentioning
confidence: 99%
“…In both ‘incomplete’ FS and BBE, the positivity of anti-GQ1b antibodies strongly supports the diagnosis, and the antibody should be measured in these regional variants. Wakerley et al 4 proposed the term, ‘ataxic hypersomnolence without ophthalmoplegia’, and it is possible that there is another reverse variant of ‘ophthalmoplegic hypersomnolence without ataxia’. BBE may be more common than we think.…”
mentioning
confidence: 99%